Who
Mark De Rosch
EVP, RA and GA and PgM
Company insider
Files Form 4 as: EVP, RA and GA and PgM, CervoMed; Chief Operating Officer, Aura Biosciences.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $14K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 28 Oct 2021
- Last trade
- 11 Feb 2026
- Last filed
- 13 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 19 Jan 2023filed 23 Jan 2023 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 | filing |
| 19 Jan 2023filed 23 Jan 2023 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —42,250 at $0.00 | filing |
| 31 Oct 2022filed 2 Nov 2022 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $14K1,115 at $12.46 | filing |
| 28 Oct 2021filed 29 Oct 2021 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 | filing |
| 28 Oct 2021filed 29 Oct 2021 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.